Case Report 🔓 Open Access CC BY 4.0

Postpartum Diagnostic Trap: RCVS–PRES Spectrum Disorder Masquerading As Post-Dural Puncture Headache Following Elective LSCS

Published in Journal of Clinical Obstetrics and Gynecology Research

Show affiliations (3)
  1. 1Department of Obstetrics and Gynecology, INHS Asvini, Colaba, Mumbai
  2. 2Department of Medicine, INHS Asvini, Colaba, Mumbai
  3. 3Department of Radiodiagnosis, INHS Asvini, Colaba, Mumbai

Published

DOI10.52338/jocogr.2026.5771 Vol 17 · 2026 ⏱ 6 min read
⬇ Download PDF

Abstract

Headache following caesarean delivery under spinal anaesthesia is a common postoperative complaint and is most frequently attributed to post-dural puncture headache (PDPH). However, clinicians must remain vigilant for secondary neurological causes - particularly when symptoms evolve atypically or fail to respond to conservative measures. These include postpartum eclampsia, Reversible Cerebral Vasoconstriction Syndrome (RCVS), and Posterior Reversible Encephalopathy Syndrome (PRES). We present a case of a 30-year-old multiparous woman who developed persistent headache following an elective lower segment caesarean section (LSCS) under spinal anaesthesia. Initially managed as PDPH, her clinical course was complicated by progressive bradycardia, acute-onset hypertension, visual disturbances, and ultimately a generalized tonic-clonic seizure. Brain MRI confirmed RCVS-PRES spectrum disorder with characteristic patchy T2/FLAIR hyperintensities in bilateral parieto-occipital regions, posterior cingulate gyrus, and bilateral lentiform nuclei. The final diagnosis was postpartum eclampsia concurrent with RCVS-PRES spectrum disorder. Multidisciplinary management with magnesium sulphate, intravenous labetalol, levetiracetam, and nimodipine resulted in complete neurological recovery and safe discharge. This case underscores the critical importance of maintaining a high index of suspicion for overlapping neurological entities in any postpartum patient with refractory headache.

1 Highlights#

  • Persistent postpartum headache unresponsive to conservative therapy must not be reflexively attributed to post-dural puncture headache (PDPH) following spinal anaesthesia.
  • Postpartum eclampsia can occur without antecedent hypertension or proteinuria, and may present with a delayed sequence of headache, visual disturbance, and seizure.
  • RCVS and PRES represent overlapping neurological entities sharing a common pathophysiology of endothelial dysfunction and cerebral autoregulatory failure, particularly in the postpartum period.
  • MRI with T2/FLAIR sequences is essential when secondary neurological causes are suspected — characteristic posterior predominant vasogenic oedema confirms PRES, while clinical context supports concurrent RCVS.
  • Early initiation of magnesium sulphate, antihypertensives, and nimodipine (calcium channel blocker) can reverse cerebral vasospasm and prevent maternal morbidity.
  • Spinal anaesthesia may be an underrecognized trigger for RCVS–PRES spectrum disorder through CSF pressure shifts and sympathetic dysregulation in susceptible postpartum women

2 Introduction#

Postpartum headache is a frequent clinical challenge encountered in obstetric and anaesthetic practice. In the setting of neuraxial anaesthesia, PDPH remains the leading diagnosis and is attributed to inadvertent or intended dural puncture, leading to cerebrospinal fluid (CSF) leakage and intracranial hypotension[1]. However, secondary causes may account for up to 40% of severe postpartum headaches, and these include potentially life-threatening conditions such as eclampsia, PRES, cerebral venous sinus thrombosis (CVST), subarachnoid haemorrhage, and RCVS[2,3].

Reversible Cerebral Vasoconstriction Syndrome (RCVS) is an increasingly recognised condition characterised by multifocal, segmental narrowing of cerebral arteries that typically resolves over days to weeks. Its hallmark clinical feature is recurrent thunderclap headache, but it may also manifest with focal neurological deficits, seizures, stroke, or visual disturbances. Posterior Reversible Encephalopathy Syndrome (PRES) represents a neuroradiological and clinical syndrome characterised by vasogenic oedema predominantly in posterior cerebral regions, associated with acute hypertension, seizures, encephalopathy, and visual symptoms[4]. Crucially, RCVS and PRES are not mutually exclusive — emerging evidence highlights a spectrum of overlapping pathophysiology involving shared endothelial dysfunction and cerebral autoregulatory failure, especially in the postpartum period[5].

The postpartum state itself is a recognised trigger for both RCVS and PRES, likely mediated by hormonal flux, haemodynamic shifts, sympathetic surges, and circulating vasoactive substances. The added variable of spinal anaesthesia — which alters CSF dynamics, sympathetic tone, and cerebrovascular reactivity — may further predispose susceptible individuals to these phenomena[6]. We report a rare case in which postpartum eclampsia with concurrent RCVS–PRES spectrum disorder initially mimicked PDPH, resulting in a delayed but ultimately successful diagnosis and recovery.

3 Case Presentation#

3.1 Patient Profile and Initial Presentation#

A 30-year-old woman (P2L2) with no known antepartum comorbidities was admitted for elective LSCS. She had no prior history of hypertension, pre-eclampsia, renal disease, or neurological illness. The procedure was performed under standard spinal anaesthesia with an uneventful intraoperative course. There were no documented complications at the time of dural puncture and no abnormalities were noted in the immediate post-anaesthetic recovery period.

On postoperative day 1, the patient began complaining of persistent headache. At this stage, vital signs remained stable and there were no focal neurological deficits. Given the recent spinal anaesthesia, a provisional diagnosis of PDPH was made, and she was managed conservatively with intravenous hydration, oral analgesics, and close observation. The headache failed to demonstrate the characteristic postural variation expected in PDPH — notably, it was not relieved by recumbency — and showed no symptomatic improvement over the subsequent 48 hours.

3.2 Clinical Deterioration#

On postoperative day 3, a new and unexplained finding emerged: the patient developed significant bradycardia with a pulse rate of 40–44 beats per minute. Blood pressure at this point remained within the normal range, and oxygen saturation was maintained between 92–95% on room air. A 12-lead ECG confirmed sinus bradycardia with no evidence of heart block or ischaemic changes. Two-dimensional echocardiography (2D ECHO) and contrast-enhanced computed tomography (CECT) of the chest and abdomen revealed no structural or pulmonary pathology. The aetiology of the bradycardia remained unexplained at this stage and, in retrospect, may have represented an early autonomic manifestation of evolving cerebral dysregulation.

By postoperative day 5, the clinical picture had escalated substantially. The patient developed acute blurring of vision alongside a sharp rise in blood pressure to 160/100 mmHg. Notably, urine spot protein was negative, and all routine blood investigations — including full blood count, renal and liver function tests, and coagulation profile — remained within normal limits. Given the constellation of persistent headache, visual disturbance, and new-onset hypertension in the postpartum setting, a clinical diagnosis of postpartum eclampsia was entertained.

Magnesium sulphate infusion was commenced according to the Zuspan regimen, and intravenous labetalol 20 mg was administered as a stat dose for acute blood pressure control. Despite these measures, at 11:00 hours the patient experienced a single episode of generalized tonic-clonic seizure, following which she was emergently transferred to the Intensive Care Unit (ICU) for close monitoring and further management.

3.3 Neuroimaging and Final Diagnosis#

Urgent MRI of the brain was performed and demonstrated patchy areas of T2/FLAIR hyperintensity involving the grey matter of bilateral parieto-occipital regions, the posterior aspect of the cingulate gyrus, bilateral lentiform nuclei, and the body of the right caudate nucleus. These findings were consistent with vasogenic oedema in a distribution characteristic of PRES (Fig 1). The co-occurrence of clinical features of cerebral vasoconstriction — in a postpartum patient without prior hypertension, presenting with headache, seizure, and visual disturbance — established the final diagnosis of Postpartum Eclampsia with RCVS–PRES Spectrum Disorder.

Figure 1 Download

3.4 Treatment and Outcome#

In the ICU, the patient was continued on magnesium sulphate infusion at 1 g/hour for seizure prophylaxis, supplemental oxygen, and intravenous antibiotics to prevent nosocomial infection. Intravenous levetiracetam was initiated for seizure control and subsequently transitioned to oral therapy. Nimodipine, a selective calcium channel blocker with established efficacy in cerebral vasospasm, was added to address the vasoconstriction component of RCVS. The patient showed progressive clinical improvement: blood pressure normalised, visual symptoms fully resolved, and no further seizure activity was recorded. She was successfully discharged in a stable neurological condition.

4 Discussion#

4.1 Diagnostic Transitions and Clinical Learning Points#

This case illustrates a challenging sequence of diagnostic transitions that are instructive for both obstetricians and anaesthesiologists. The initial presentation was entirely consistent with PDPH — a well-recognised complication following spinal anaesthesia. However, several atypical features should have prompted earlier re-evaluation. The headache lacked postural character, was unresponsive to conservative therapy, and was later accompanied by neurological symptoms absent in PDPH. The principle that headache following neuraxial anaesthesia is PDPH until proven otherwise is clinically convenient but potentially dangerous, particularly when warning signs evolve.

Postpartum eclampsia, which accounts for 20–30% of all eclamptic seizures, is well recognised to occur without antecedent hypertension or proteinuria during the antenatal period, as observed in this patient. The classical prodrome of persistent headache, followed by visual disturbance, acute hypertension, and finally seizure — though temporally extended over five days in this case — mirrors the established pathophysiological cascade. The absence of proteinuria does not exclude the diagnosis, as endothelial dysfunction and cerebral autoregulatory failure can manifest independently of renal proteinuria[6,7].

The concurrent identification of RCVS–PRES spectrum disorder reflects the growing recognition that these are not isolated entities but rather interrelated expressions of a common pathophysiological substrate. RCVS is characterised by reversible segmental cerebral arterial vasoconstriction with clinical improvement over weeks[8]. PRES reflects the downstream consequence of failed cerebral autoregulation — when arterial pressure overwhelms the vasculature's protective vasoconstriction, breakthrough hyperperfusion and vasogenic oedema ensue. In the postpartum setting, both are driven by hormonal changes, heightened sympathetic activity, and circulating vasoactive mediators including endothelin-1 and serotonin[9,10].

4.2 Role of Spinal Anaesthesia#

The potential contributory role of spinal anaesthesia in precipitating or unmasking RCVS–PRES in susceptible individuals deserves consideration. Subarachnoid injection alters CSF pressure dynamics acutely, and compensatory cerebrovascular responses to these shifts may trigger vasoreactivity in predisposed vessels[11]. Additionally, the acute sympatholysis following spinal block, and subsequent rebound sympathetic surge during recovery, may contribute to the haemodynamic instability that predisposes cerebral autoregulatory failure. The unexplained bradycardia observed on day 3 may have represented an aberrant autonomic response within this context[12].

4.3 Differential Diagnosis and Exclusion#

The differential diagnosis for this presentation was broad and included PDPH, cerebral venous sinus thrombosis (CVST), intracranial haemorrhage, meningitis, and isolated PRES or RCVS. CT brain and CT angiography excluded haemorrhagic stroke and significant cerebral venous pathology[13,14]. The characteristic MRI pattern of posterior predominant vasogenic oedema without diffusion restriction, in the context of postpartum onset, acute hypertension, seizure, and clinical recovery with appropriate therapy, cemented the RCVS–PRES diagnosis (Table1)[15].

Table 1 Summary of the key differentiating features between postpartum RCVS and PRES across clinical presentation, neuroimaging, and management — highlighting their overlapping spectrum.

Table 1 Summary of the key differentiating features between postpartum RCVS and PRES across clinical presentation, neuroimaging, and management — highlighting their overlapping spectrum.
FeaturePostpartum RCVSPostpartum PRES
CLINICAL FEATURES
HeadacheThunderclap; recurrent, severe Hallmark featureDiffuse, progressive; less abrupt Often gradual onset
SeizuresLess common (~20–30%) Seen in severe casesProminent (~60–75%) Often the presenting feature
Visual symptomsTransient blurring, scotomata IntermittentCortical blindness, hemianopia Prominent feature
HypertensionVariable; may be absent Not required for diagnosisTypically severe (>160/110 mmHg) Usually present
EncephalopathyUncommon unless stroke complicates RareConfusion, drowsiness, agitation Common
ProteinuriaAbsent Not a featureVariable; present if eclampsia overlap May be absent
Postpartum onsetDays to 4 weeks Peak: week 1–2Usually within 48–72 hours Peak: first 24–72 hrs
CourseMonophasic; resolves over weeks Generally benignResolves days–weeks with treatment Reversible
IMAGING FINDINGS
MRI T2/FLAIROften normal early May show cortical SAH or infarct laterPatchy hyperintensity in parieto-occipital regions Hallmark finding
DistributionAnterior > posterior Territorial if infarct presentPosterior predominant Parieto-occipital, cerebellar, lentiform nuclei
DWI / ADCRestricted diffusion if ischaemic stroke DWI bright / ADC darkFacilitated diffusion (vasogenic oedema) DWI dark / ADC bright
MRA / CTAMultifocal segmental vasoconstriction "String-and-beads" patternUsually normal vessels Vascular imaging unaffected
DSA (angiography)Definitive; confirms reversible vasoconstriction Gold standardTypically normal; not required Not a routine investigation
HaemorrhageCortical SAH, lobar ICH possible Significant complication riskRare haemorrhagic transformation Uncommon
MRI enhancementNo parenchymal enhancement Typically absentLeptomeningeal enhancement in some cases Occasional finding
Imaging reversibilityVasoconstriction resolves in 4–12 weeks Confirm on follow-up MRAOedema resolves in days–weeks Confirm on follow-up MRI
PATHOPHYSIOLOGY & MANAGEMENT
Core mechanismSegmental cerebral arterial vasospasm Vasoconstriction predominatesFailed cerebrovascular autoregulation Vasogenic oedema from hyperperfusion
CSF findingsNormal or mildly elevated protein Near normalNormal Not diagnostic
Key treatmentNimodipine (calcium channel blocker) Avoid vasoconstrictors and triptansBP control: labetalol, hydralazine Magnesium sulphate if eclampsia co-exists
PrognosisGood; stroke risk if untreated Vigilance for complicationsExcellent with treatment Rare recurrence

5 Conclusion#

This case powerfully demonstrates that persistent postpartum headache following spinal anaesthesia must not be reflexively attributed to PDPH. A thorough, dynamic clinical re-evaluation is essential whenever headache proves refractory to conservative management, lacks typical postural characteristics, or is accompanied by any neurological symptom — however subtle. The triad of headache, visual disturbance, and hypertension in the postpartum period must raise urgent suspicion for eclampsia and RCVS–PRES spectrum disorder.

Timely neuroimaging — particularly MRI with FLAIR sequences — is essential for diagnosis when secondary causes are suspected. Early administration of magnesium sulphate for seizure prophylaxis and prevention of cerebral vasospasm, combined with targeted antihypertensive therapy and calcium channel blockers such as nimodipine to address vasoconstriction, represents the cornerstone of management. Multidisciplinary collaboration between obstetrics, anaesthesiology, neurology, and critical care is vital in navigating these complex presentations.

As RCVS–PRES spectrum disorder becomes increasingly recognised in the postpartum population, awareness among frontline clinicians must keep pace. The maternal outcome in this case was excellent precisely because the diagnosis was ultimately made and treatment escalated appropriately. Vigilance, clinical flexibility, and a willingness to look beyond the most common diagnosis remain the most powerful tools in postpartum neurological care.

Declarations

◎Competing interests

The authors have no conflicts of interest to disclose.

♥Acknowledgements

Nil

Article information

  1. Published
cc

Copyright © 2026 Dr. Shazia Khan. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. CC BY 4.0 · Corrections policy

Cite this articleKhan S, Krishnamurthy A, Mukherjee A, Girdhar S, Grewal R. Postpartum Diagnostic Trap: RCVS–PRES Spectrum Disorder Masquerading As Post-Dural Puncture Headache Following Elective LSCS. Journal of Clinical Obstetrics and Gynecology Research. 2026;17. doi: 10.52338/jocogr.2026.5771
PDF JATS XML

References 15#

  1. 1

    Joudi N, Ansari J. Postpartum headaches after epidural or spinal anesthesia. Curr Opin Obstet Gynecol. 2021 Apr 01;33(2):94-99

    PubMedGoogle Scholar↩ Back to text

  2. 2

    Goldszmidt E, Kern R, Chaput A, Macarthur A. The incidence and etiology of postpartum headaches: a prospective cohort study. Can J Anaesth. 2005 Nov;52(9):971-7.

    PubMedGoogle Scholar↩ Back to text

  3. 3

    Khoromi S. Secondary headaches in pregnancy and the puerperium. Front Neurol. 2023;14:1239078

    PubMedGoogle Scholar↩ Back to text

  4. 4

    Chen SP, Wang SJ. Pathophysiology of reversible cerebral vasoconstriction syndrome. J Biomed Sci. 2022 Sep 21;29(1):72

    PubMedGoogle Scholar↩ Back to text

  5. 5

    Jeanneret V, Jillella DV, Rangaraju S, et al. PRES and RCVS: Two Distinct Entities or a Spectrum of the Same Disease?. J Stroke Cerebrovasc Dis. 2022;31(6):106472. doi:10.1016/j.jstrokecerebrovasdis.2022.106472

    DOIPubMedGoogle Scholar↩ Back to text

  6. 6

    American College of Obstetricians and Gynecologists. Gestational hypertension and preeclampsia. ACOG Practice Bulletin No. 222. Obstet Gynecol. 2020;135(6):e237–e260.

    PubMedGoogle Scholar↩ Back to text

  7. 7

    Stella CL, Jodicke CD, How HY, Harkness UF, Sibai BM. Postpartum headache: is your work-up complete? Am J Obstet Gynecol. 2007;196(4):318.e1–318.e7.

    PubMedGoogle Scholar↩ Back to text

  8. 8

    Sveinsson O, Love Á, Vilmarsson V, Olafsson I. [Reversible cerebral vasoconstriction syndrome - a common cause of thunderclap headache]. Laeknabladid. 2020 Feb;106(2):79-83

    PubMedGoogle Scholar↩ Back to text

  9. 9

    Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015;14(9):914–925.

    PubMedGoogle Scholar↩ Back to text

  10. 10

    Bartynski WS. Posterior reversible encephalopathy syndrome, Part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008;29(6):1043–1049

    PubMedGoogle Scholar↩ Back to text

  11. 11

    Safran SL, Balmer C, Savoldelli G. Reversible cerebral vasoconstriction syndrome during caesarean section. BMJ Case Rep. 2019 Dec 5;12(12):e230606. doi: 10.1136/bcr-2019-230606.

    DOIPubMedGoogle Scholar↩ Back to text

  12. 12

    Doelakeh ES, Chandak A. Risk Factors in Administering Spinal Anesthesia: A Comprehensive Review. Cureus. 2023 Dec 4;15(12):e49886. doi: 10.7759/cureus.49886.

    DOIPubMedGoogle Scholar↩ Back to text

  13. 13

    Perillo T, Paolella C, Perrotta G, Serino A, Caranci F, Manto A. Reversible cerebral vasoconstriction syndrome: review of neuroimaging findings. Radiol Med. 2022 Sep;127(9):981-990

    PubMedGoogle Scholar↩ Back to text

  14. 14

    Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007 Dec;130(Pt 12):3091-101

    PubMedGoogle Scholar↩ Back to text

  15. 15

    Bartynski WS. Posterior reversible encephalopathy syndrome, Part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008;29(6):1036–1042

    PubMedGoogle Scholar↩ Back to text

Cite this article

Share this article

Figure

Table